• Fri, January 27, 2023
Michael Ulz Maintained (ALVR) at Buy with Decreased Target to $20 on, Jan 27th, 2023
Michael Ulz of Morgan Stanley, Maintained "AlloVir, Inc." (ALVR) at Buy with Decreased Target from $27 to $20 on, Jan 27th, 2023.
Michael has made no other calls on ALVR in the last 4 months.
There is 1 other peer that has a rating on ALVR. Out of the 1 peers that are also analyzing ALVR, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $19 on, Monday, January 23rd, 2023
